Lianli Ma

675 total citations
26 papers, 568 citations indexed

About

Lianli Ma is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Lianli Ma has authored 26 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Lianli Ma's work include Xenotransplantation and immune response (10 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Lianli Ma is often cited by papers focused on Xenotransplantation and immune response (10 papers), T-cell and B-cell Immunology (7 papers) and Immunotherapy and Immune Responses (5 papers). Lianli Ma collaborates with scholars based in United States, Canada and China. Lianli Ma's co-authors include Anita S. Chong, Jikun Shen, Dengping Yin, Huasong Zeng, Yijin Li, Leonard Blinder, Guerard W. Byrne, Preston Foster, James W. Williams and James A. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Lianli Ma

26 papers receiving 563 citations

Peers

Lianli Ma
Angus W. Thomson United States
Bryna E. Burrell United States
William H. Kitchens United States
Gülçin Demirci United States
Leonard Blinder United States
Sohail Saleem United States
Sherri Y. Chan United States
Anu Soots Finland
Angus W. Thomson United States
Lianli Ma
Citations per year, relative to Lianli Ma Lianli Ma (= 1×) peers Angus W. Thomson

Countries citing papers authored by Lianli Ma

Since Specialization
Citations

This map shows the geographic impact of Lianli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianli Ma more than expected).

Fields of papers citing papers by Lianli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianli Ma. The network helps show where Lianli Ma may publish in the future.

Co-authorship network of co-authors of Lianli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lianli Ma. A scholar is included among the top collaborators of Lianli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianli Ma. Lianli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Heming, Shanshan Liang, Ping Yao, et al.. (2021). Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients. Translational Cancer Research. 10(1). 288–297. 8 indexed citations
2.
Liang, Shanshan, Gang Wang, Xuening Ji, et al.. (2020). The prognostic role of a combined fibrinogen and inflammation- based index in patients with metastatic breast cancer. Translational Cancer Research. 9(11). 7065–7078. 7 indexed citations
3.
Hughey, Curtis C., Lianli Ma, Freyja D. James, et al.. (2013). Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovascular Diabetology. 12(1). 128–128. 18 indexed citations
4.
Ma, Lianli, Yijin Li, Dengping Yin, et al.. (2009). Memory Alloreactive B Cells and Alloantibodies Prevent Anti-CD154-Mediated Allograft Acceptance. The Journal of Immunology. 182(3). 1314–1324. 42 indexed citations
5.
Ma, Lianli, et al.. (2009). CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous tolerance. Liver Transplantation. 15(8). 915–923. 8 indexed citations
6.
Wang, Lei, Lianli Ma, Zhongyi Chen, et al.. (2009). Deficiency of Protein Kinase C-Theta Facilitates Tolerance Induction. Transplantation. 87(4). 507–516. 14 indexed citations
7.
Wang, Tong‐Min, Luqiu Chen, Emily Ahmed, et al.. (2008). Prevention of Allograft Tolerance by Bacterial Infection with Listeria monocytogenes. The Journal of Immunology. 180(9). 5991–5999. 73 indexed citations
8.
Li, Yijin, Lianli Ma, Dengping Yin, Jikun Shen, & Anita S. Chong. (2008). Long-Term Control of Alloreactive B Cell Responses by the Suppression of T Cell Help. The Journal of Immunology. 180(9). 6077–6084. 15 indexed citations
9.
Ma, Lianli, Taylor P. Sherrill, Lei Wang, et al.. (2008). Bioluminescence Imaging Visualizes Activation of Nuclear Factor-κB in Mouse Cardiac Transplantation. Transplantation. 85(6). 903–910. 16 indexed citations
10.
Ding, Jin, Tingting Zhou, Huasong Zeng, et al.. (2008). Hyperacute Rejection by Anti-Gal IgG1, IgG2a, and IgG2b Is Dependent on Complement and Fc-γ Receptors. The Journal of Immunology. 180(1). 261–268. 22 indexed citations
11.
Yin, Dengping, Huasong Zeng, Lianli Ma, et al.. (2004). Cutting Edge: NK Cells Mediate IgG1-Dependent Hyperacute Rejection of Xenografts. The Journal of Immunology. 172(12). 7235–7238. 51 indexed citations
12.
Zeng, Huasong, W. James Waldman, Deng Ping Yin, et al.. (2004). Mechanistic Study of Malononitrileamide FK778 in Cardiac Transplantation and CMV Infection in Rats. Transplantation. 79(1). 17–22. 25 indexed citations
13.
Yin, Dengping, et al.. (2003). IFN-γ Production Is Specifically Regulated by IL-10 in Mice Made Tolerant with Anti-CD40 Ligand Antibody and Intact Active Bone. The Journal of Immunology. 170(2). 853–860. 14 indexed citations
14.
Yin, Dengping, et al.. (2002). Intact Active Bone Transplantation Synergizes with Anti-CD40 Ligand Therapy to Induce B Cell Tolerance. The Journal of Immunology. 168(10). 5352–5358. 16 indexed citations
15.
Yin, Dengping, et al.. (2002). CTLA-4Ig in Combination with Anti-CD40L Prolongs Xenograft Survival and Inhibits Anti-Gal Ab Production in GT-Ko Mice. American Journal of Transplantation. 2(1). 41–47. 13 indexed citations
16.
Dujovny, Nadav, Jikun Shen, Dengping Yin, et al.. (2002). Acute Xenograft Rejection Mediated by Antibodies Produced Independently of TH1/TH2 Cytokine Profiles. American Journal of Transplantation. 2(6). 526–534. 12 indexed citations
17.
Yin, Dengping, Lianli Ma, Howard Sankary, et al.. (2002). Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts1. Transplantation. 74(9). 1236–1241. 9 indexed citations
18.
Yin, Dengping, Howard Sankary, Lianli Ma, et al.. (2001). LEWIS RAT PANCREAS, BUT NOT CARDIAC XENOGRAFTS, ARE RESISTANT TO ANTI-GAL ANTIBODY MEDIATED HYPERACUTE REJECTION 1. Transplantation. 71(10). 1385–1389. 7 indexed citations
19.
Chong, Anita S., Leonard Blinder, Lianli Ma, et al.. (2000). Anti-galactose-α(1,3) galactose antibody production in α1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transplant Immunology. 8(2). 129–137. 20 indexed citations
20.
Chong, Anita S., Wan‐Yun Huang, Wei Liu, et al.. (1999). IN VIVO ACTIVITY OF LEFLUNOMIDE. Transplantation. 68(1). 100–109. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026